We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1721:TSEFSM Holdings Limited Analysis

Data as of 2026-07-07 - not real-time

¥5,445.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

COMSYS is trading at ¥5,445, just above its 20‑day SMA of ¥5,421 but slightly under the 50‑day SMA of ¥5,475, indicating a near‑term equilibrium. The 14‑day RSI sits at 50.6, suggesting neutral momentum, while the MACD histogram remains strongly positive, giving a bullish signal. Volatility over the past 30 days is about 19 %, and the computed beta of essentially zero points to minimal market‑wide price swings. Fundamentally, the company posts a 4.6 % revenue growth rate and a solid free‑cash‑flow conversion, supporting its 2.44 % dividend yield. However, the DCF‑derived fair value of ¥3,850 is far below the current price, implying a downside of roughly 10 %. The PE of 17.6 is well under the industry average of 32.2, highlighting a value‑oriented earnings multiple.
Given the modest growth, strong cash position and a payout ratio of 42 %, the dividend appears sustainable. The balance sheet shows low leverage (debt‑to‑equity ≈ 0.6) and ample liquidity. Sector‑specific risks are moderate, but regulatory and geographic exposures are limited to Japan, keeping those risks low. Overall, the stock is presently overvalued, but its defensive characteristics and attractive yield make it a candidate for a hold‑to‑collect strategy, with potential upside if the price re‑aligns toward its intrinsic value.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram despite price near short‑term support
  • Dividend yield of 2.44% with sustainable payout
  • Current price modestly above 20‑day SMA

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable cash flow and low leverage
  • Revenue growth of 4.6% supporting earnings
  • Valuation gap between market price and DCF fair value

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong balance sheet and defensive dividend profile
  • Low beta and limited geographic exposure
  • Potential mean‑reversion toward intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin5.76%
P/E Ratio17.6
ROE9.37%
ROA5.76%
Debt/Equity0.59
P/B Ratio1.6
Op. Cash Flow¥42.5B
Free Cash Flow¥25.3B
Industry P/E32.2

Technical Analysis

TrendNeutral
RSI50.6
Support¥5,277.00
Resistance¥5,625.00
MA 20¥5,420.75
MA 50¥5,475.44
MA 200¥4,815.80
MACDBullish
VolumeStable
Fear & Greed Index93

Valuation

Fair Value¥3,850.53
Target Price¥4,880.00
Upside/Downside-10.38%
GradeOvervalued
TypeValue
Dividend Yield2.44%

Risk Assessment

Beta0.03
Volatility19.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.